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We hypothesized that acute hyperglycemia (200 mg/dL) would increase 
H2O2 and decrease NO levels in blood relative to saline group. By contrast, 
MitoQ and the SS-31 peptide would attenuate acute hyperglycemia-
induced oxidative stress (e.g., H2O2) and improve vascular function (e.g., 
increase NO production) under acute hyperglycemia. 
We found that acute hyperglycemia significantly reduced blood NO levels 
compared to saline group. The administration of MitoQ or SS-31 during 
hyperglycemia significantly improved blood NO levels, similar to saline 
control. Meanwhile we found acute hyperglycemia maintained a higher level 
of H2O2 in blood compared to saline group. By contrast, MitoQ or SS-31 
during hyperglycemia significantly reduced blood H2O2 levels compared to 
those under hyperglycemia. Moreover, SS-31 treatment showed a trend to 
reduce blood H2O2 levels more than those in MitoQ treatment, but was not 
significant. These results suggest that mitochondrial derived SO is a 
significant source of oxidative stress and vascular endothelial dysfunction 
under acute hyperglycemic conditions. Moreover, treatment with 
mitochondrial-targeted antioxidants, MitoQ or SS-31, may be beneficial to 
attenuate hyperglycemia induced oxidative stress and vascular endothelial 
dysfunction.  
Male Sprague-Dawley rats (275 to 325g, Charles River, Springfield, MA) 
were anesthetized with 60 mg/kg of pentobarbital sodium with 1000 unit 
heparin via intraperitoneal (i.p.) injections. The jugular vein was catheterized 
to allow for the infusion of  saline, 20% D-glucose, or 20% D-glucose with 
1.86 mg/kg MitoQ (MW=600 g/mol; complexed with cyclodextrin to improve 
water solubility, total MW=1714 g/mol) or with 2.7 mg/kg SS-31 (MW=640 
g/mol, Genemed Synthesis, Inc., San Antonio, TX). The continuous infusion 
of 20% D-glucose solution was to maintain hyperglycemia around 200 
mg/dL for about 180 min. MitoQ or SS-31 was added to 20% glucose to 
reach approximately 13 µM and 50 µM in blood, respectively. Both femoral 
veins will be exposed and catheterized in order to place the calibrated NO 
and H2O2 microsensors (100 μm, WPI Inc., Sarasota, FL) at random into 
each femoral vein. These microsensors were then connected to the Apollo 
4000 free radical analyzer (WPI Inc., Sarasota, FL) to measure for blood NO 
and H2O2 levels in real-time. NO, H2O2, and glucose levels will then be 
recorded at baseline and at 20 minute intervals throughout the 180 minute 
infusion period [2].  
The changes of blood NO (nM) and H2O2 (M) levels were expressed as the 
relative change to the baseline or to saline group, respectively. All the data 
was represented as a mean ± SEM. The data were then analyzed by 
ANOVA using post hoc analysis with the Student Newman Keuls. p<0.05 
was considered as significant. 
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Diabetes and prediabetes are major public concerns worldwide due to the 
high risk of developing micro- and macro-vascular complications. 
Hyperglycemia, the major criteria for diabetes diagnosis, is causally related 
to pathogenesis of vascular complications in diabetic patients. One of early 
events in hyperglycemia is vascular endothelial dysfunction.  Normally, 
vascular endothelium facilitates blood flow principally by releasing 
endothelial-derived nitric oxide (NO) via vascular endothelial NO synthase 
(eNOS) in the presence of tetrahydrobiopterin (BH4).  By contrast, acute 
and chronic hyperglycemia increase oxidative stress and reduces NO 
bioavailability [1, 2]. The reduced endothelial-derived NO bioavailability 
promotes vasoconstrictive, pro-inflammatory, and pro-thrombotic events, 
initiating inflammation and eventually resulting in tissue/organ damage 
(Figure 1).  Therefore, reduction of oxidative stress under hyperglycemia 
will mitigate vascular endothelial dysfunction and organ damage.  Crabtree 
et al found that mitochondria-derived superoxide (SO) contributes to 
hyperglycemia-induced oxidative stress in cultured vascular endothelial 
cells.  Subsequently, the overproduction of SO promotes the eNOS to shift 
its product from NO to SO due to oxidation of BH4 to dihydrobiopterin (BH2) 
[1] (Figure 1). However, the role of mitochondria in acute hyperglycemia-
induced oxidative stress and blood NO reduction has not been evaluated in 
vivo.  Recently, our lab showed that mitoquinone (MitoQ) and SS-31 
(Szeto-Schiller, D-Arg-Dmt-Lys-Phe-Amide) peptide (Figure 2), 
mitochondria-targeted antioxidants, significantly reduced blood H2O2 (an 
index of oxidative stress) and increased blood NO in a hind limb 
ischemia/reperfusion (I/R) animal model [3].  Oxidative stress is also an 
important cause of reperfusion injury during I/R. Thus, we hypothesize that 
MitoQ and SS-31 will reduce blood oxidative stress and increase blood NO 
under acute hyperglycemic conditions.  
Figure 1. Possible role of mitochondrial-derived SO in hyperglycemia-induced  
oxidative stress, vascular endothelial dysfunction and tissue inflammation. 
Figure  3. Blood glucose level among saline and 20% glucose infusion groups. 
Figure 4. The comparison of change in blood NO levels relative to baseline among 
saline, 20% D-glucose, 20% D-glucose with MitoQ (13 M),  and 20% D-glucose 
with SS-31 (50 M) groups (*p<0.05, **p<0.01 vs D-glucose). 
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Figure 2. Chemical structure of MitoQ and SS-31 Adapted from Szeto 2008 [4]. 
Figure 5. The comparison of change in blood H2O2 levels relative to saline group 
among 20% D-glucose, 20% D-glucose with MitoQ (13 M),  and 20% D-glucose 
with SS-31 (50 M) (#p<0.05, ##p<0.01 vs saline; *p<0.05, **p<0.01 vs D-glucose). 
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